目前同步放化疗已成为局部晚期鼻咽癌的标准治疗。
Concomitant radiochemotherapy has become the standard treatment of local advanced nasopharyngeal carcinoma now.
医生发现，与只接受同步放化疗的患者相比，接受诱导治疗和同步放化疗的患者，其总生存率升高较小，但很显著。
Doctors found a small but significant increase in overall survival in the patients who received the induction therapy with chemoradiation versus the chemoradiation-only group.
结论：同步放化疗治疗局部晚期非小细胞肺癌具有较好的疗效，不良反应可耐受，治疗失败原因主要为远处转移。
Conclusions: Concurrent radiochemotherapy is a feasible, well tolerated and active scheme in the treatment of locally advanced NSCLC. The major pattern of failure is distant metastasis.
目的观察紫杉醇脂质体未作预处理在同步放化疗治疗中晚期宫颈癌中的疗效及安全性。
Objective:To observe the curative effect of hypertherapy with concurrent chemotherapy and radiotherapy in treating the patients with locally advanced cervix cancer.
目的观察紫杉醇脂质体未作预处理在同步放化疗治疗中晚期宫颈癌中的疗效及安全性。
Objective:To observe the curative effect of hypertherapy with concurrent chemotherapy and radiotherapy in treating the patients with locally advanced cervix cancer.
应用推荐